ANKRD26-related thrombocytopenia 2 with a baseline increase in blasts: implications for clinical surveillance.
Saved in:
| Title: | ANKRD26-related thrombocytopenia 2 with a baseline increase in blasts: implications for clinical surveillance. |
|---|---|
| Authors: | Wahlster L; Division of Hematology/Oncology, Boston Children's Hospital, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Godley LA; Division of Hematology/Oncology, Lurie Children's Hospital, Northwestern Medicine, Chicago, IL., Cheng JX; Department of Pathology, The University of Chicago, Chicago, IL., Drazer MW; Sections of Hematology/Oncology and Genetic Medicine, Department of Medicine, The University of Chicago Comprehensive Cancer Center, Chicago, IL., Reilly CR; Division of Hematological Malignancies, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Pinkus GS; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Rowe JH; Division of Hematology/Oncology, Boston Children's Hospital, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Weichert-Leahey N; Division of Hematology/Oncology, Boston Children's Hospital, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Rowe RG; Division of Hematology/Oncology, Boston Children's Hospital, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Gorfinkel L; Division of Hematology/Oncology, Boston Children's Hospital, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Brundige K; Division of Hematology/Oncology, Boston Children's Hospital, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Wachter F; Division of Hematology/Oncology, Boston Children's Hospital, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Messa L; Division of Hematology/Oncology, Boston Children's Hospital, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Michelson AD; Division of Hematology/Oncology, Boston Children's Hospital, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Cantor AB; Division of Hematology/Oncology, Boston Children's Hospital, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Shimamura A; Division of Hematology/Oncology, Boston Children's Hospital, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Bledsoe JR; Department of Pathology, Boston Children's Hospital, Harvard Medical School, Boston, MA. |
| Source: | Blood [Blood] 2025 Jul 10; Vol. 146 (2), pp. 254-259. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
